FTXH

First Trust Nasdaq Pharmaceuticals ETF
*Unless otherwise stated, data provided by FactSet.

FTXH Fund Description

FTXH tracks the most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.

FTXH Factset Analytics Insight

The First Trust NASDAQ Pharmaceutical ETF tracks an index of highly liquid pharmaceutical stocks weighted according to various factors. While many funds perform a basic liquidity screen as part of their index construction and rebalancing, FTXH is noteworthy because it goes beyond the basic screen and uses liquidity selection. The 30 most liquid pharmaceutical stocks in the U.S are chosen for inclusion in the index as determined by the average daily traded volume over three months. The securities are then ranked and weighed according to value, volatility, and growth factors. Value is measured using a cash flow to price metric. The trailing one- year volatility provides another factor. Growth is considered using the average of the three- month, six- month, nine- month, and twelve- month price return.. FTXH’s expense ratio is higher than comparable funds in this segment.

FTXH MSCI ESG Analytics Insight

First Trust Nasdaq Pharmaceuticals ETF has an MSCI ESG Fund Rating of BB based on a score of 4.21 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. First Trust Nasdaq Pharmaceuticals ETF ranks in the 23th percentile within its peer group and in the 30th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

FTXH Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 12/12/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
FTXH 7.98% 10.85% 20.09% 10.68% 8.96% -- --
FTXH (NAV) 8.29% 11.28% 19.53% 9.33% 9.29% -- --
Thomson Reuters US Pharmaceuticals -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

FTXH Summary Data

First Trust
09/20/16
Open-Ended Fund
0.60%
$9.08M
$50.02K
0.43%

FTXH Portfolio Data

$92.33B
77.30
5.24
0.66%
12/13/19
30

FTXH Index Data

Multi-Factor
Liquidity
Thomson Reuters US Pharmaceuticals

FTXH Portfolio Management

0.60%
--
--
--

FTXH Tax Exposures

20.00% / 39.60%
0.64%
Qualified dividends
No

FTXH Fund Structure

Open-Ended Fund
No
No
100% / 0%
N/A
N/A
High
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

FTXH Factset Analytics Block Liquidity

As of 12/13/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of FTXH. FTXH is rated a 4 out of 5.

FTXH Tradability

2,345
$50.02K
530
$12.59K
0.43%
$0.09
-0.01%
2.69% / -3.77%
None
100.00%
50,000
0.01
0.04%
0.07%
0
$22.99
4

FTXH Sector/Industry Breakdown


FTXH
Segment Benchmark
58.91%
89.18%
9.60%
--
7.59%
4.50%
7.42%
--
6.94%
0.25%
5.26%
0.64%
4.27%
--

FTXH Top 10 Holdings[View All]

Pfizer Inc. 7.69%
AbbVie, Inc. 4.79%
61.11%

FTXH Countries


FTXH
Segment Benchmark
100.00%
100.00%

FTXH Regions


FTXH
Segment Benchmark
100.00%
100.00%

FTXH Economic Development


FTXH
Segment Benchmark
100.00%
100.00%

FTXH Performance Statistics

0.73
1.06
1.18
0.93
0.63%
Thomson Reuters US Pharmaceuticals

FTXH MSCI ESG Ratings

4.21 / 10
29.54
23.00
--
22.18%
31.32

FTXH Benchmark Comparison Holdings

30
52
18
43.41%

FTXH Benchmark Comparison Summary


FTXH
Segment Benchmark
30
52
$92.33B
$179.42B
77.30
24.83
5.24
5.21
1.41%
2.50%
High
High

FTXH Benchmark Comparison Market Cap Size


FTXH
Segment Benchmark
51.74%
95.43%
25.17%
3.20%
23.09%
1.16%
0.00%
0.21%